This includes activation of TF by the oncogenic epidermal growth factor receptor (EGFR), with corresponding studies on glioma [14,15,16], epidermoid [14,17,18], colorectal [18], breast [19] and endometrial carcinoma cells [20]. This evidence concerns the gene TF and central nervous system cancer.